Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 4 (February 1), 2007: pp. 384-389
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.7800

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Axtell, A. E.
Right arrow Articles by Holschneider, C. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Axtell, A. E.
Right arrow Articles by Holschneider, C. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer

Allison E. Axtell, Margaret H. Lee, Robert E. Bristow, Sean C. Dowdy, William A. Cliby, Steven Raman, John P. Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz, Ilana Cass, Andrew J. Li, Beth Y. Karlan, Christine H. Holschneider

From the University of California Los Angeles (UCLA) Medical Center; Olive View-UCLA Medical Center; Cedars-Sinai Medical Center; Kaiser Permanente Sunset Medical Center, Los Angeles, CA; Johns Hopkins Medical Institutions, Baltimore, MD; and the Mayo Clinic, Rochester, MN

Address reprint requests to Christine H. Holschneider, MD, Olive View-UCLA Medical Center, Department of Obstetrics and Gynecology, 14445 Olive View Dr, Rm 2B-163, Sylmar, CA 91342; e-mail: CHolschneider{at}ladhs.org

Purpose Identify features on preoperative computed tomography (CT) scans to predict suboptimal primary cytoreduction in patients treated for advanced ovarian cancer in institution A. Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C.

Patients and Methods Preoperative CT scans from patients with stage III/IV epithelial ovarian cancer who underwent primary cytoreduction in institution A between 1999 and 2005 were retrospectively reviewed by radiologists blinded to surgical outcome. Fourteen criteria were assessed. Crossvalidation was performed by applying predictive model A to the patients from cohorts B and C, and reciprocally applying predictive models B and C to cohort A.

Results Sixty-five patients from institution A were included. The rate of optimal cytoreduction (≤ 1 cm residual disease) was 78%. Diaphragm disease and large bowel mesentery implants were the only CT predictors of suboptimal cytoreduction on univariate (P < .02) and multivariate analysis (P < .02). In combination (model A), these predictors had a sensitivity of 79%, a specificity of 75%, and an accuracy of 77% for suboptimal cytoreduction. When model A was applied to cohorts B and C, accuracy rates dropped to 34% and 64%, respectively. Reciprocally, models B and C had accuracy rates of 93% and 79% in their original cohorts, which fell to 74% and 48% in cohort A.

Conclusion The high accuracy rates of CT predictors of suboptimal cytoreduction in the original cohorts could not be confirmed in the cross validation. Preoperative CT predictors should be used with caution when deciding between surgical cytoreduction and neoadjuvant chemotherapy.

Presented in part during plenary presentations at the 34th Annual Meeting of the Western Association of Gynecologic Oncologists, Santa Fe, NM, June 15-18, 2005; and at the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, CA, March 22-26, 2006.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
RadioGraphicsHome page
P. T. Johnson, K. M. Horton, and E. K. Fishman
Nonvascular Mesenteric Disease: Utility of Multidetector CT with 3D Volume Rendering
RadioGraphics, May 1, 2009; 29(3): 721 - 740.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. S. Chi, P. T. Ramirez, J. B. Teitcher, S. Mironov, D. M. Sarasohn, R. B. Iyer, E. L. Eisenhauer, N. R. Abu-Rustum, Y. Sonoda, D. A. Levine, et al.
Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less
J. Clin. Oncol., November 1, 2007; 25(31): 4946 - 4951.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. N. Fader and P. G. Rose
Role of Surgery in Ovarian Carcinoma
J. Clin. Oncol., July 10, 2007; 25(20): 2873 - 2883.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online